Close

Press Releases

Mundipharma enters partnership with Samsung Bioepis to expand biosimilars into Hong Kong and Taiwan

Mundipharma announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong. The partnership covers Samsung Bioepis’ biosimilar candidates in the field of immunology and oncology, including SB5 (adalimumab), SB4 (etanercept), SB3 (trastuzumab),...

Development of First-In-Class Antibody Therapeutics and New Acquisition Brings Hope to Patients with Fibrotic and Inflammatory Diseases

The breakthrough discovery of investigational therapies for multiple human diseases by a team of Singapore clinicians, clinician scientists and scientists from National Heart Centre Singapore (NHCS), SingHealth Duke-NUS AMC and the Singapore based biotech company Enleofen Bio, along with...

BioAsia to promote innovations in Life Science and Healthcare through Start-up Stage in its 17th Edition

Asia's largest Life-sciences and healthcare forum BioAsia, will continue to feature a dedicated platform - Start-up Stage in its 17th edition to be held at Hyderabad between February 17th to 19th February 2020. The Start-up Stage at BioAsia 2020...

Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use

Signant Health announced a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Health’s digital health platform for asthma and COPD (chronic obstructive pulmonary disease). The partnership will help drive patient adherence to inhaled medications...

Amgen commences strategic collaboration with BeiGene to expand oncology presence in China

Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world's second-largest pharmaceutical market. BeiGene is a commercial-stage research-based...

ideaPoint Partners with SAS to Provide Leading Data Sharing Solution Through ClinicalStudyDataRequest.com

Anaqua’s ideaPoint, a leading provider of innovation management solutions, has announced a partnership with SAS, the world leader in analytics. The partnership will provide to pharmaceutical companies and academic researchers the most robust clinical trial data sharing solution, with...

Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics

Velabs Therapeutics GmbH, a biotech company focused on the rapid screening of functional therapeutic antibodies announced that it has entered into an exclusive licence agreement with alytas therapeutics GmbH , for the development and commercialization of alytas’ antibodies in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read